Form 4 for KYMR Kymera Therapeutics, Inc.
Accepted 2024-02-29 00:00:00 ET · period of report 2024-02-27 · accession 0000950170-24-023168 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2024-02-29 | 2024-02-27 | KYMR | Gollob Jared | Chief Medical Off | M - OptEx | $2.08 | +400 | 75.1K | +0.5% | +$832 |
| DT | 2024-02-29 | 2024-02-27 | KYMR | Gollob Jared | Chief Medical Off | S - Sale+OE | $45.00 | -400 | 74.7K | -0.5% | -$18.0K |
| DT | 2024-02-29 | 2024-02-27 | KYMR | Gollob Jared | Chief Medical Off | M - OptEx | $0.00 | -400 | 62.5K | -0.6% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-27 | M | A | 400 | $2.08 | 75,109 | D | — | — | |
| 2 | Common | Common Stock | 2024-02-27 | S | D | 400 | $45.00 | 74,709 | D | — | — | |
| 3 | Derivative | Stock Option (Right to Buy) | 2024-02-27 | M | D | 400 | $0.00 | 62,483 | D | $2.08 · — to 2029-05-22 | 400 Common Stock | (F2) The shares underlying this stock option vest in forty-eight (48) equal monthly installments following the vesting commencement date of February 7, 2019, subject to the reporting person's continued employment through each vesting date. |